Omeros | OMER - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Adma Biologics USD 26.74M 6.55M 2026-03
Alnylam Pharmaceuticals USD 347.92M 65.41M 2026-06
BioMarin Pharmaceutical USD 395.55M 137.27M 2026-06
Cytokinetics USD 104.4M 499K 2026-06
Gilead Sciences USD 1.52B 70M 2026-06
Heron Therapeutics USD 23.74M 605K 2025-12
Immunic USD 3.45M 451K 2025-12
Insmed USD 247.47M 208K 2026-06
Knight Therapeutics CAD 35.45M 4.43M 2025-12
MacroGenics USD 9.71M 1.77M 2026-03
Omeros USD 11.32M 2.48M 2024-09
Pacira USD 91.81M 7.93M 2026-06
Pfizer USD 3.41B 496M 2026-06
Rockwell Medical USD 4.04M 330K 2024-06
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Sarepta Therapeutics USD 107.6M 53.57M 2026-06
United Therapeutics USD 206.7M 50.1M 2026-06
Vertex Pharmaceuticals USD 582.2M 88.5M 2026-06